Advertisement

Advertisement

Quick Chats

hematologic malignancies
immunotherapy

By The ASCO Post Staff  / Quick Chats

Andrew D. Zelenetz, MD, PhD, and Stephen J. Schuster, MD, on CAR T Cells for Hematologic Malignancies: Where We’re At

multiple myeloma

By The ASCO Post Staff  / Quick Chats

Paul G. Richardson, MD, and Peter M. Voorhees, MD, on Multiple Myeloma: Surveying the Evolving Landscape of Up-Front Drugs

colorectal cancer
gastrointestinal cancer

By The ASCO Post Staff  / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Liquid Biopsies for Colorectal and Other GI Cancers

colorectal cancer
genomics/genetics

By The ASCO Post Staff  / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Colorectal Cancer: Molecular Testing and Interpreting an NGS Report

Advertisement

Advertisement



Aug
04
Today In Oncology
‘Durable Clinical Activity’ Reported With Tislelizumab in Advanced Liver Cancer
Maintaining a Healthy Lifestyle May Decrease Cancer Incidence in High-Risk Individuals
Racial/Ethnic Disparities in Emergency Department Visits After Breast Cancer Surgery
Pulsed Vincristine/Dexamethasone Maintenance in Pediatric Acute Lymphoblastic Leukemia
Tremelimumab, Durvalumab, or Both in Unresectable Hepatocellular Carcinoma
View More 
Advertisement
© 2021 HSP News Service, L.L.C.
Designed by Harborside